Vaxcell-Bio Therapeutics Co., Ltd. (323990.KQ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 13Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−6.7x

Market Cap

KRW 104.42B

MomentumView details →

1D Return

−10.56%

YTD Return

−54.15%

RSI (14)

56.0

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−6.7x

Market Cap

KRW 104.42B

RSI (14)

56.0

MomentumView details →

1D Return

−10.56%

YTD Return

−54.15%

ProfitabilityView details →

Gross Margin

−18.75%

Net Margin

−229.11%

EBITDA Margin

−207.75%

ROE (TTM)

−28.00%

ROA (TTM)

−25.42%

Asset Turnover

0.11x

GrowthView details →

Revenue YoY

+17.35%

EPS YoY

−21.22%

FCF YoY

−72.46%

Revenue CAGR 3Y

+2167.56%

EPS CAGR 3Y

−24.71%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.03x

Current Ratio

5.56x

Quick Ratio

5.46x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

6.51B

Net Income (TTM)

−14.92B

Op. CF (TTM)

−10.61B

Latest newsMore news →

No recent news for 323990.KQ.

Similar companies

ORIENT BIO Inc.002630.KS Sino Biopharmaceutical Limited01177.HK iNtRON Biotechnology, Inc.048530.KQ MedPacto, Inc.235980.KQ Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.06990.HK Innovent Biologics, Inc.01801.HK Find similar companies →

Latest newsMore news →

No recent news for 323990.KQ.